In a groundbreaking endeavor, Canadensys Aerospace is developing Canada's first-ever rover to explore the Moon, part of NASA's Artemis program. This mission aims to find water and prepare for future manned missions, marking a significant step in space exploration.
NASA's new Mission Evaluation Room at the Johnson Space Center enhances monitoring for Artemis 2, the crewed flight test of the Orion spacecraft. With 24/7 data analysis, this facility ensures safety and paves the way for future lunar missions.
NASA is down to 25 finalists for the Artemis II zero gravity indicator, a plush mascot for the crew's historic mission around the Moon. The public has a chance to influence the design that will join astronauts on their journey into space!
In a controversial move, NASA's acting Administrator Sean Duffy announced a shift away from climate science to prioritize space exploration, echoing budget proposals that threaten key Earth science missions. This shift raises concerns about future climate monitoring and weather forecasting.
Prepare for an exhilarating launch as NASA and SpaceX send 5,000 pounds of vital supplies and groundbreaking experiments to the International Space Station. Tune in for live coverage!
China's space program is making significant strides towards landing astronauts on the Moon by 2030, potentially beating NASA in this new space race. With successful tests of their lunar lander and rocket, analysts suggest the implications for global power dynamics could be monumental.
In a groundbreaking move, Novartis has received approval for Coartem® Baby, the first malaria treatment specifically designed for newborns and young infants, addressing a critical healthcare gap in malaria-endemic regions.
President Trump's budget bill has passed, bringing significant changes to NASA's future. While funding for Artemis missions is restored, critical science programs face devastating cuts. The Planetary Society warns of an 'extinction-level event' for NASA's research initiatives.
Swiss authorities have approved Coartem Baby, the first malaria treatment for newborns under 11 pounds, addressing a significant health gap for vulnerable infants. This sweet cherry-flavored drug can be mixed with breast milk, making it easier to administer.
During a recent test of NASA's new solid rocket booster, an anomaly was spotted, raising questions about future missions. Learn what went wrong and its implications for the Artemis program.
